Because surgeons are innately skeptics, progress in surgery rarely occurs abruptly. However, because we are also enthusiasts and optimists, there is almost always a spirited forum for examining new techniques and concepts and for reexamining old ones. Experience has shown us that there are many ways of achieving nearequal results. No one has a comer on success.
The statisticians tell us that prospective -randomized studies provide the sine qua non of data. But experience has also shown us that evenlhis methodology has shortcomings when we deal with pathology, physiology, and people. Randomization results can be flawed because variables may. be overfooked or improperly weighted. Patients may be excluded from randomization because ofbias towardone treatment orother,etc. Moreoften, the time required to conclude these studies is too lengthy to provide meaningful current clinical guidelines. Frequently, there is an ethical dilemma surrounding the possibility of withholding treatment that might be beneficial because of the absence of hard data.
The onus for accepting new ideas falls upon the individual surgeon. Almost above all else, training should have prepared us to critically evaluate new therapies. Do they make sense? Is the evidence compelling? Is the author experienced? What is the author's track record? What is the downside from the patient perspective? Are the risks more serious without treatment than with the current therapy?
While we must keep an open mind to new ideas even when they are unappealing, we must never forget that we are the patient's advocate, and the bottom line always is the net effect on a patient. We must resist techniques merely because they appear to make sense or because they appeal to our emotional or egocentric needs when there is a lack of acceptable data. Frequently we are helped in this process by the open discussion of these dilemmas by experienced and contemplative people who can bring to the table the thought processes that led them to accept or to reject suggestion for change.
In this issue, the Asian Cardiovascular Exchange (ACE) Group has very thoughtfully and incisively summarized the presentation of opposing viewpoints on four current controversies in coronary artery bypass graft (CABG) surgery:
1. Continuous warm retroperfusion of the coronary sinus as an alternative to conventional methods of myocardial protection; 2. exclusive use of arterial conduits in CABG surgery; 3. an upper age beyond which CABG surgery should not be performed; and 4. the value of CABG surgery in patients with depressed left ventricular function.
The panel members who participated in the debate are all experienced and talented surgeons, each of whom presentedcompelling evidence to support his position.
I should like to add a few thoughts for consideration. First, myocardial preservation, albeit with some significant changes, has come full cycle after almost thirty years to again espouse continuous warm cardioplegia.
The changes include a different concentration of potassium, addition of metabolites, correction of pH and osmolality, and retrograde coronary sinus perfusion. The previous shortcomings appear not to have been completely overcome. Interruption of cardioplegic perfusion for whatever reasons can produce the unpleasant seqiiela so common three decades ago-high incidence of myocardial damage as evidenced by perioperative myocardial infarction and low cardiac output postpump. It would appear that hypothermia is still necessary to provide optimal myocardial protection. The most successful techniques are those that blend normotherniic induction and arrest with hypothermia during the intracardiac manipulation.
The question of the exclusive use of arterial conduits in CABG surgery will &quire additional time to answer. Remember, it took ten years to establish that the internal mammary artery was a superior conduit, and that this superiority could only be demonstrated in bypasses to the left anterior descending artery. The value of the right internal mammary artery either as a pedicle or as a free graft has not as yet been so clearly shown. The inferior epigastric and the gastroepiploic arteries remain attractive options, although differences in inherent physiologi-16A
